Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

NCT01460875 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

William Carson

Collaborators